Cel Sci (CVM) Other Accumulated Expenses (2015 - 2020)
Cel Sci (CVM) posted Other Accumulated Expenses of $5000.0 for Q1 2020, little changed sequentially from $5000.0 in Q4 2019, and down 64.24% YoY from $13984.0 in Q2 2019.
Cel Sci (CVM) Other Accumulated Expenses (2015 - 2020) Analysis & Trends
Cel Sci has reported Other Accumulated Expenses for 6 years, with the latest figure at $5000.0 in Q1 2020.
- Quarterly Other Accumulated Expenses fell 64.24% year-over-year to $5000.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $5000.0 (down 64.24% YoY) and the FY2019 annual result came in at $14956.0, up 6.61% from the prior year.
- Other Accumulated Expenses steadied at $5000.0 in Q1 2020 per CVM's latest filing, from $5000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $16009.0 in Q2 2019 and troughed at $3310.0 in Q3 2016.
- A 5-year average of $11003.5 and a median of $12449.0 in 2017 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2016 and 2017: Other Accumulated Expenses plunged 82.6% in 2016, then surged 276.1% in 2017.
- Over 5 years, Other Accumulated Expenses stood at $7203.0 in 2016, then soared by 64.03% to $11815.0 in 2017, then climbed by 16.54% to $13769.0 in 2018, then slumped by 63.69% to $5000.0 in 2019, then changed by 0.0% to $5000.0 in 2020.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $5000.0, $5000.0, and $14956.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 14,956.00 |
| Jun 30, 2019 | 16,009.00 |
| Mar 31, 2019 | 13,984.00 |
| Dec 31, 2018 | 13,769.00 |
| Sep 30, 2018 | 14,029.00 |
| Jun 30, 2018 | 14,290.00 |
| Mar 31, 2018 | 14,576.00 |
| Dec 31, 2017 | 11,815.00 |
| Sep 30, 2017 | 12,449.00 |
| Jun 30, 2017 | 10,871.00 |
| Mar 31, 2017 | 7,792.00 |
| Dec 31, 2016 | 7,203.00 |
| Sep 30, 2016 | 3,310.00 |
| Sep 30, 2015 | 19,025.00 |